Rhona Stein

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.

Chris Waskewich, Rosalyn D. Blumenthal, Honglan Li et al. · PubMed · 2002 · 203 citations

Medicine, Oncology, Pharmacology +13

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.

David M. Goldenberg, Jo Ann Horowitz, Robert M. Sharkey et al. · Journal of Clinical Oncology · 1991 · 202 citations

Medicine, Nuclear Medicine, Oncology +17

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

Josette Carnahan, Rhona Stein, Zhengxing Qu et al. · Molecular Immunology · 2006 · 174 citations

Pharmacy, Immunology, Oncology +14

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Rhona Stein, Zhengxing Qu, Susan Chen et al. · Clinical Cancer Research · 2004 · 170 citations · Full text

Pharmacy, Immunology, Oncology +17

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Puja Sapra, Rhona Stein, J. Pickett et al. · Clinical Cancer Research · 2005 · 169 citations

Medicine, Oncology, Pharmacology +17